| CDY Minimum Holding Share Buy-Back |
| 19/03/19 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4D, Half Year Accounts and Strategy Update |
| 21/02/19 | PRICE SENSITIVE | | Share |
|
| CDY Significant New Findings Published on Midkine |
| 07/02/19 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C and Notes to Appendix 4C |
| 23/01/19 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Expects Record Sales in Q2 FY2019 |
| 12/12/18 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Appoints Exclusive New Zealand Distributor |
| 19/11/18 | PRICE SENSITIVE | | Share |
|
| CDY New Patents for Midkine Antibodies in USA and Europe |
| 07/11/18 | PRICE SENSITIVE | | Share |
|
| CDY Ikon Legal Action - Decision |
| 02/11/18 | PRICE SENSITIVE | | Share |
|
| CDY Trading Halt |
| 02/11/18 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid's Evolis Successfully Launched in USA stores |
| 01/11/18 | PRICE SENSITIVE | | Share |
|
| CDY Repayment of R&D Loan |
| 01/11/18 | PRICE SENSITIVE | | Share |
|
| CDY Investor Presentation |
| 31/10/18 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C and Notes to Appendix 4C |
| 15/10/18 | PRICE SENSITIVE | | Share |
|
| CDY Lead Antibody Effective in Rare Chronic Kidney Disease |
| 12/09/18 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Share Purchase Plan Completion |
| 03/09/18 | PRICE SENSITIVE | | Share |
|
| CDY Evolis USA Distribution Update |
| 30/08/18 | PRICE SENSITIVE | | Share |
|
| CDY Preliminary Final Report |
| 24/08/18 | PRICE SENSITIVE | | Share |
|
| CDY Cleansing Notice and Appendix 3B |
| 06/08/18 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Share Purchase Plan |
| 31/07/18 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Share Placement Raises $9M |
| 31/07/18 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C and Notes to Appendix 4C |
| 31/07/18 | PRICE SENSITIVE | | Share |
|
| CDY Trading Halt |
| 27/07/18 | PRICE SENSITIVE | 141.88KB | Share |
|
| CDY CELLMID UPDATES ON DISTRIBUTION OF EVOLIS |
| 11/07/18 | PRICE SENSITIVE | 178.82KB | Share |
|
| CDY CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET |
| 02/05/18 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS |
| 24/04/18 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 23/04/18 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA |
| 04/04/18 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4D and Half Year Accounts |
| 22/02/18 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 25/01/18 | PRICE SENSITIVE | | Share |
|
| CDY RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS |
| 10/01/18 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID QUARTERLY OPERATIONAL UPDATE |
| 09/01/18 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID PLACEMENT TO STRATEGIC INVESTOR |
| 15/12/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLIS |
| 07/12/17 | PRICE SENSITIVE | | Share |
|
| CDY YPB: Agreement with Cellmid to access Chinese health market |
| 28/11/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID OPENS FIRST CONCEPT STORE IN TOKYO |
| 26/10/17 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 25/10/17 | PRICE SENSITIVE | | Share |
|
| CDY PROPOSED CONSOLIDATION OF SECURITIES |
| 24/10/17 | PRICE SENSITIVE | | Share |
|
| CDY Consolidation/Split - CDY |
| 23/10/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID RECEIVES $947K R&D TAX CREDIT |
| 03/10/17 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4E and Preliminary Final Report |
| 30/08/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID COMPLETES US CONSUMER STUDY |
| 21/08/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLIS |
| 03/08/17 | PRICE SENSITIVE | | Share |
|
| CDY Chinese Import Permits Received |
| 01/08/17 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 28/07/17 | PRICE SENSITIVE | | Share |
|
| CDY Nature Paper MK in Melanoma |
| 03/07/17 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 19/04/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHED |
| 02/03/17 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid to Refinance R&D Loan Facility |
| 01/03/17 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4D and Half Year Accounts |
| 28/02/17 | PRICE SENSITIVE | | Share |
|
| CDY MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCE |
| 07/02/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED |
| 31/01/17 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C |
| 24/01/17 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMME |
| 18/01/17 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Updates on CxBladder License |
| 12/12/16 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid receives 831K R&D tax credit |
| 29/11/16 | PRICE SENSITIVE | | Share |
|
| CDY USA launch of evolis-CDY.AX |
| 03/11/16 | PRICE SENSITIVE | | Share |
|
| CDY USA launch of evolis |
| 03/11/16 | PRICE SENSITIVE | | Share |
|
| CDY ASX Market Release - Reinstatement-CDY.AX |
| 01/11/16 | PRICE SENSITIVE | | Share |
|
| CDY Suspension from Official Quotation-CDY.AX |
| 28/10/16 | PRICE SENSITIVE | | Share |
|
| CDY Trading Halt-CDY.AX |
| 26/10/16 | PRICE SENSITIVE | | Share |
|
| CDY CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS-CDY.AX |
| 10/10/16 | PRICE SENSITIVE | | Share |
|
| CDY Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer-CDY.AX |
| 05/10/16 | PRICE SENSITIVE | | Share |
|
| CDY European Midkine Patent For Surgical Adhesion Allowed-CDY.AX |
| 22/09/16 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4E and Preliminary Final Report-CDY.AX |
| 30/08/16 | PRICE SENSITIVE | | Share |
|
| CDY New Publication for Cellmid's Midkine Antibody-CDY.AX |
| 09/08/16 | PRICE SENSITIVE | | Share |
|
| CDY Transcript of Cellmid Investor Briefing Call-CDY.AX |
| 29/07/16 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly-CDY.AX |
| 26/07/16 | PRICE SENSITIVE | | Share |
|
| CDY Ikon Legal Action,WPP-CDY.AX |
| 22/07/16 | PRICE SENSITIVE | | Share |
|
| CDY USA Distribution Partnership for Cellmid's Evolis-CDY.AX |
| 20/07/16 | PRICE SENSITIVE | | Share |
|
| CDY MK antibody publication and patent in bone healing-CDY.AX |
| 24/06/16 | PRICE SENSITIVE | | Share |
|
| CDY MK antibody publication and patent in bone healing-CDY.AX |
| 24/06/16 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly-CDY.AX |
| 21/04/16 | PRICE SENSITIVE | | Share |
|
| CDY Midkine Strategy Update-CDY.AX |
| 08/04/16 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid to Refinance RnD Loan |
| 26/02/16 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4D and Half Year Accounts |
| 25/02/16 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 27/01/16 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid receives $1.12M R&D Tax Credit |
| 11/12/15 | PRICE SENSITIVE | | Share |
|
| CDY Key Antibody Patent Granted in Europe |
| 01/12/15 | PRICE SENSITIVE | | Share |
|
| CDY Japanese Patent granted for use of Midkine for Hair Growth |
| 24/11/15 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 27/10/15 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4E and Preliminary Final Report |
| 31/08/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Launching Major Advertising Campaign |
| 27/08/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid appoints EAS to support US Strategy |
| 12/08/15 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 30/07/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid raises $4M to leverage sales growth |
| 30/07/15 | PRICE SENSITIVE | | Share |
|
| CDY Trading Halt |
| 28/07/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Revenue Guidance Upgrade |
| 09/07/15 | PRICE SENSITIVE | | Share |
|
| CDY US Patent for Anti-Midkine Antibodies Granted |
| 29/06/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Announces Brain Cancer Program |
| 23/06/15 | PRICE SENSITIVE | | Share |
|
| CDY Positive Toxicology Study Results for CAB102 |
| 15/06/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Signs Agreement with Maywufa |
| 02/06/15 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Secures $1M Loan Funding |
| 15/05/15 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 29/04/15 | PRICE SENSITIVE | | Share |
|
| CDY Positive Clinical Results for Cellmid Hair Growth Product |
| 15/04/15 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4D and Half Year Accounts |
| 24/02/15 | PRICE SENSITIVE | | Share |
|
| CDY Appendix 4C - quarterly |
| 28/01/15 | PRICE SENSITIVE | | Share |
|
| CDY USA Patent Granted for Treatment of Heart Failure |
| 21/01/15 | PRICE SENSITIVE | | Share |
|
| CDY Australian Patent Granted for Use of Midkine for Hair Growth |
| 12/01/15 | PRICE SENSITIVE | | Share |
|
| CDY Key Midkine Antibody Patent Granted |
| 15/12/14 | PRICE SENSITIVE | | Share |
|
| CDY Cellmid Capital Raising |
| 15/12/14 | PRICE SENSITIVE | | Share |
|
